Aytu BioScience's Return On Capital Employed Overview
According to data from Benzinga Pro, during Q2, Aytu BioScience's (NASDAQ:AYTU) reported sales totaled $23.12 million. Despite a 58.54% increase in earnings, the company posted a loss of $11.55 million.
Benzinga ·
Benzinga
